(1)
Li, X.; He, J.; Song, C. Research Progress on the CDK4 6 Signaling Pathway and Clinical Application of Its Inhibitors in HR+ HER2- Breast Cancer. Health Nexus 2025, 1, 31-37. https://doi.org/10.63802/healthnexus.V1.2025.148.